On October 18th, a paper titled “A multimechanistic antibody targeting receptor-binding sites potently cross-protects against influenza B viruses” was published online by Science Translational Medicine, a companion to Nature. It is a teamwork of the research group led by Prof. Xia Ningshao with School of Life Sciences and School of Public Health.
The research was supported by State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics (XMU), National Institute of Diagnostics and Vaccine Development in Infectious Diseases and Joint Laboratory for Biological Medicine of Yangshengtang Group and Xiamen University. The paper was coauthored by four doctoral students, Shen Chenguang, Chen Junyu, Li Rui and Wang Guosong, and one master’s student Zhang Mengya, and corresponding authors are Associate Pro. Chen Yixin and Prof. Xia Ningshao. The research received technical supports from State Key Laboratory for Emerging Infectious Diseases (HKU)and Sanofi Pasteur Inc., and funds from National Natural Science Foundation of China, National Science and Technology Major Project for “Significant New Drugs Development”, and HK Science & Technology Cooperation Program of Ministry of Science and Technology.